Mehdi Brahmi, MD PhD (he/him/his)

Physician
Department of Medical Oncology, Centre Léon Bérard,, France

Mehdi Brahmi, MD PhD, is a medical oncologist. He achieved his MD from the Medical School at the University of Grenoble (France) in 2015. Following this, he attended the Centre Léon Bérard (CLB), the comprehensive cancer centre of Lyon and the Rhône-Alpes region, and has concluded a PhD thesis in 2020 on molecular characterization of rare sarcomas in the Cancer Research Center of Lyon (INSERM U1052-CNRS5286).

Poster(s):

• (P 026) IS THERE STILL A PLACE FOR BONE MARROW SAMPLING IN VERY HIGH RISK EWING SARCOMA? ROLE OF FDG PET/CT IN THE INITIAL STAGING OF VERY HIGH RISK EWING SARCOMA IN A PROSPECTIVE PHASE II MULTICENTRIC STUDY.

• (P 189) PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA

• (P 238) EXPANDING THE MOLECULAR SPECTRUM OF GIANT CELL TUMORS.